ArticleFrontiers in oncology2022

Durable effect of pyrotinib plus capecitabine in HER-2+ breast cancer patient undergoing peritoneal dialysis: A case report and literature review.

Xiangting Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.